Showing results (221-230 of 231) with videos related to
Sort By:
Pageof 24
Neurobiology of Aging|June 27, 2006
Clinical significance of corpus callosum atrophy in a mixed elderly populationC Ryberg, E Rostrup, M B Stegmann, et al.Journal of the Neurological Sciences|May 31, 2011
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohortC Ryberg, E Rostrup, O B Paulson, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Grey zone amyloid burden affects memory function: the SCIENCe projectJ L Ebenau, S C J Verfaillie, K A van den Bosch, et al.Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.Acta Neuropathologica Communications|October 23, 2022
Plasma proteome profiling identifies changes associated to AD but not to FTDR Babapour Mofrad, M Del Campo, C F W Peeters, et al.Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.Pageof 24